Urinary biomarkers in bladder cancer: A review of the current landscape and future directions
K Ng, A Stenzl, A Sharma, N Vasdev - Urologic Oncology: Seminars and …, 2021 - Elsevier
Aim This narrative review aims to describe established and emerging urinary biomarkers in
the diagnosis and surveillance of non-muscle invasive bladder cancer. It provides a …
the diagnosis and surveillance of non-muscle invasive bladder cancer. It provides a …
Urine biomarkers in bladder cancer—Current status and future perspectives
Urine markers to detect bladder cancer have been the subject of research for decades. The
idea that urine—being in continuous contact with tumour tissue—should provide a vector of …
idea that urine—being in continuous contact with tumour tissue—should provide a vector of …
The Paris system for reporting urinary cytology: the quest to develop a standardized terminology
The main purpose of urine cytology is to detect high-grade urothelial carcinoma (HGUC).
With this principle in mind, The Paris System (TPS) Working Group, composed of …
With this principle in mind, The Paris System (TPS) Working Group, composed of …
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning
F Tian, D Liu, N Wei, Q Fu, L Sun, W Liu, X Sui… - Nature Medicine, 2024 - nature.com
Cancer of unknown primary (CUP) site poses diagnostic challenges due to its elusive
nature. Many cases of CUP manifest as pleural and peritoneal serous effusions. Leveraging …
nature. Many cases of CUP manifest as pleural and peritoneal serous effusions. Leveraging …
Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer
We report an approach in diagnostic imaging based on nanoscale-resolution scanning of
surfaces of cells collected from body fluids using a recent modality of atomic force …
surfaces of cells collected from body fluids using a recent modality of atomic force …
Performance of an artificial intelligence algorithm for reporting urine cytopathology
Background Unlike Papanicolaou tests, there are no commercially available computer‐
assisted automated screening systems for urine specimens. Despite The Paris System for …
assisted automated screening systems for urine specimens. Despite The Paris System for …
Biomarkers in bladder cancer surveillance
SS Sugeeta, A Sharma, K Ng, A Nayak… - Frontiers in …, 2021 - frontiersin.org
Aim: This is a narrative review with an aim to summarise and describe urinary biomarkers in
the surveillance of non-muscle-invasive bladder cancer (NMIBC). It provides a summary of …
the surveillance of non-muscle-invasive bladder cancer (NMIBC). It provides a summary of …
Current status of urinary biomarkers for detection and surveillance of bladder cancer
A Mbeutcha, I Lucca, R Mathieu, Y Lotan… - Urologic …, 2016 - urologic.theclinics.com
With an estimated 74,000 new cases and 16,000 deaths for 2015, BC is the fifth most
frequent malignancy in the United States. 1 Urothelial carcinoma of the bladder (UCB) …
frequent malignancy in the United States. 1 Urothelial carcinoma of the bladder (UCB) …
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective …
T Lebret, X Paoletti, G Pignot, M Roumiguié… - World journal of …, 2023 - Springer
Purpose Cytology and cystoscopy, the current gold standard for diagnosing urothelial
carcinomas, have limits: cytology has high interobserver variability with moderate or not …
carcinomas, have limits: cytology has high interobserver variability with moderate or not …
Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging
Background Bladder cancer (BC) is among the most common cancers diagnosed in men in
the USA. The current gold standards for the diagnosis of BC are invasive or lack the …
the USA. The current gold standards for the diagnosis of BC are invasive or lack the …